Therapy and prophylaxis of Pneumocystis carinii pneumonia
Dutz, W.; Post, C.; Jennings-Khodadad, E.; Fakouhi, T.; Kohout, E.; Bandarizadeh, B.
National Cancer Institute Monograph 43: 179-185
1976
ISSN/ISBN: 0083-1921 PMID: 828241 Document Number: 102701
A review is given of the therapeutic efficacy of pentamidine and of sulphadoxine plus pyrimethamine for the treatment of Pneumocystis infections in man. Illustrations are given from the epidemic of interstitial plasma cell pneumonia in infants at the Shiraz Orphanage in Iran. Prophylactic drug treatment might be advantageous for infants or adults at risk from this infection.
Document emailed within 1 workday
Related Documents
Buskin, S.E.; Newcomer, L.M.; Koutsky, L.A.; Hooton, T.M.; Spach, D.H.; Hopkins, S.G. 1999: Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia, and death in persons with AIDS Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 20(2): 201-206Oka, M.; Noguchi, Y.; Matsumoto, Y.; Tsurukawa, Y.; Kawano, K.; Araki, J.; Mine, Y.; Kanda, T.; Saito, A.; Hara, K. 1985: Five cases of Pneumocystis carinii pneumonia diagnosed by bronchofiberscopy--the usefulness of the bronchoalveolar lavage for diagnosis of Pneumocystis carinii pneumonia Nihon Kyobu Shikkan Gakkai Zasshi 23(9): 1052-1058
O'Doherty, M.J.; Bateman, N.T. 1991: Prophylaxis and treatment of Pneumocystis carinii pneumonia British Journal of Hospital Medicine 45(5): 277-8 280 283
Saah, A.J.; Hoover, D.R.; Peng, Y.; Phair, J.P.; Visscher, B.; Kingsley, L.A.; Schrager, L.K. 1995: Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study JAMA 273(15): 1197-1202
Monforte, A.D.; Mainini, F.; Bini, T.; Moscatelli, G.C.; Antinori, S.; Formenti, T.; Testa, L.; Mena, M.; Moroni, M. 1995: Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS Journal of ChemoTherapy 7(Suppl): 184-186
Centers For Disease Control And Prevention (Usa). 1995: 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus Morbidity and Mortality Weekly Report 44(RR4): 1-11
Goebel, F.D.; Bogner, J.R. 1995: Therapy and prevention of pneumocystis carinii pneumonia Der Internist 36(12): 1150-1155
Haberthür, C.; Pless, M.; Tichelli, A.; Gratwohl, A.; Speck, B.; Betticher, D.C. 1994: Pneumocystis carinii pneumonia during therapy with 2-chlorodeoxyadenosine (2-CDA) Schweizerische Medizinische Wochenschrift 124(1-2): 73-78
Wassermann, K.; Scheidt-Mackes, M.; Zeidler, D. 1988: Problems in adjuvant therapy with corticosteroids in AIDS-associated Pneumocystis carinii pneumonia Praxis und Klinik der Pneumologie 42(12): 867-871
Safrin, S.; Sattler, F.R.; Lee, B.L.; Young, T.; Bill, R.; Boylan, C.T.; Mills, J. 1991: Dapsone as a single agent is suboptimal therapy for Pneumocystis carinii pneumonia Journal of Acquired Immune Deficiency Syndromes 4(3): 244-249
Saga, T.; Minami, S.; Okafuji, K.; Koshino, T.; Ishizaki, T.; Miyabo, S. 1982: Transbronchial lung biopsy in Pneumocystis carinii pneumonia following therapy of adult leukemia Nihon Kyobu Shikkan Gakkai Zasshi 20(9): 984-990
MacFadden, D.K.; Edelson, J.D.; Rebuck, A.S. 1985: Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome: response to inadvertent steroid therapy Canadian Medical Association Journal 132(10): 1161-1163
May, T.; Beuscart, C.; Reynes, J.; Marchou, B.; Leclercq, P.; Borsa Lebas, F.; Saba, J.; Micoud, M.; Mouton, Y.; Canton, P. 1994: Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMi Study Group. Ligue Française de Prévention des Maladies Infectieuses Journal of Acquired Immune Deficiency Syndromes 7(5): 457-462
Thea, D.M.; Lambert, G.; Weedon, J.; Matheson, P.B.; Abrams, E.J.; Bamji, M.; Straus, W.L.; Thomas, P.A.; Krasinski, K.; Heagarty, M. 1996: Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. new York City Perinatal HIV Transmission Collaborative Study Group Pediatrics 97(1): 59-64
Lozano, F.; Lozano, M.C.; Sánchez, A.; León, E.; García-Bragado, F. 1993: Haemophilus influenzae pneumonia simulating Pneumocystis carinii pneumonia in an HIV-infected patient Enfermedades Infecciosas y Microbiologia Clinica 11(5): 287-288
Helm, E.B.; Staszewski, S.; Arasteh, K.; Jacobi, V.; Mulert, R.; Wegner, R.; Ottmann, O.; Brodt, H.R.; L'age, M.; Stille, W. 1990: Comparison of the effect of 2 therapy concepts in the treatment of Pneumocystis carinii pneumonia. Cotrimoxazole for 21 days versus sequential therapy with cotrimoxazole followed by pentamidine inhalation Medizinische Klinik 85(Suppl 2): 264-267
Ruffini, D.D.; Madhi, S.A. 2002: The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia Aids 16(1): 105-112
Nakamura, T. 2003: Pneumocystis carinii pneumonia Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 2): 576-580
Mojon, M. 1972: Pneumocystis carinii pneumonia Lyon Medical 228(16): 311-323
Ikemoto, H.; Mori, T. 1971: Pneumocystis carinii pneumonia Nihon Rinsho. Japanese Journal of Clinical Medicine 29(9): 2137-2145